IP Library Granted Patent US 7,714,121
Granted Patent B2
US 7,714,121 · App. 10/695,499 · Granted May 11, 2010

Meningococcal antigens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,714,121
App. No.
10/695,499
Granted
May 11, 2010
Kind
B2
Abstract

The invention provides proteins from Neisseria meningitidis (strains A & B), including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.

Claims (8)

1. An isolated nucleic acid molecule which encodes a protein comprising an amino acid sequence of SEQ ID NO:4.

2. A nucleic acid molecule according to claim 1 , comprising a nucleotide sequence of SEQ ID NO:3.

3. An isolated nucleic acid molecule encoding an immunogenic polypeptide having 90% or greater sequence identity to an amino acid sequence of SEQ ID NO:4, wherein the immunogenic polypeptide can raise antibodies which specifically bind to SEQ ID NO:4.

4. An isolated nucleic acid molecule comprising a fragment of 25 or more nucleotides of a nucleotide sequence of SEQ ID NO:3, wherein the fragment is capable of detecting N. meningitidis nucleic acids through hybridization under high stringency conditions comprising a wash in 0.1×SSC, 0.5% SDS solution at 65° C.

5. An isolated nucleic acid molecule encoding an immunogenic polypeptide, wherein the isolated nucleic acid molecule can hybridize to a nucleic acid molecule which encodes a protein comprising an amino acid sequence of SEQ ID NO:4 under high stringency conditions comprising a wash in 0.1×SSC, 0.5% SDS solution at 65° C., wherein the isolated nucleic acid molecule is capable of detecting N. meningitidis nucleic acids through hybridization.

6. An isolated nucleic acid molecule that encodes a protein comprising an immunogenic fragment of at least 20 consecutive amino acids of an amino acid sequence of SEQ ID NO:4, wherein the immunogenic fragment can raise antibodies which specifically bind to SEQ ID NO:4.

7. The isolated nucleic acid molecule of claim 3 wherein the immunogenic polypeptide has 99% or greater sequence identity to an amino acid sequence of SEQ ID NO:4.

8. The isolated nucleic acid molecule of claim 3 wherein the immunogenic polypeptide has 95% or greater sequence identity to an amino acid sequence of SEQ ID NO:4.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2009
From: SCARLATO, VINCENZO; MASIGNANI, VEGA; RAPPUOLI, RINO; PIZZA, MARIAGRAZIA; GRANDI, GUIDO
To: CHIRON SPA
Reel/Frame 023584/0808 →
CHANGE OF NAME Recorded Dec 1, 2009
From: CHIRON SPA
To: CHIRON SRL
Reel/Frame 023584/0834 →
CHANGE OF NAME Recorded Dec 1, 2009
From: CHIRON SRL
To: NOVARTIS VACCINES AND DIAGNOSTICS SRL
Reel/Frame 023584/0896 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2008
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 021806/0474 →